With years of executive management experience as a clinical laboratory scientist, Ms. Tannenbaum owned and ran a successful independent clinical laboratory for over 21 years before starting two non profits to raise funds for ME/CFS research.
Fulfilling a promise to their daughter, who came down with sudden onset ME/CFS at the age of 16 in 2006, Ms. Tannenbaum and her husband had started their first non-profit Neuro-Immune Disease Alliance (NIDA). to raise funds from family and friends. Ms. Tannenbaum soon realized that open, global collaborative research was lacking and founded Open Medicine Foundation (OMF) in 2012 to take the efforts to a much larger level to fund and facilitate large research projects to find a cure for ME/CFS and other similar chronic illnesses.
Ms. Tannenbaum received her degree in Bacteriology from UCLA in 1978 and her Clinical Laboratory Scientist/Medical Technology license in 1979.
Ms. Hicks is currently providing consulting and advisory services to boards, investors, and management teams on building value-adding and sustainable for-profit and nonprofit organizations. She is a finance industry veteran, with over twenty years of leadership experience across both private and public sectors, and she most recently served as chief administrative officer of the International Securities Exchange.
Ms. Hicks has successfully worked with top management and boards on firm-wide strategy, acquisition integrations, business operations, risk and cost management, compensation programs, talent management practices, and board practices. Early in her career, she also co-led a program for autistic children and adults.
In addition to serving on our board, she is also a board member of Boys Town NY and is a founding member of the Association of Women Entrepreneurs and Executives in their New York chapter. Ms. Hicks holds master of arts degree. in Industrial/Organizational Psychology from St. Mary’s University and a bachelor of arts degree in Psychology from The University of Texas. As a patient, she is personally focused on solving the big questions of the causes and treatments for neuro-immune disorders.
Ms. Linsley is a senior vice president of Crescent Capital Group LP. She is responsible for directing Crescent’s charitable giving activities. She is also responsible for coordinating Crescent’s annual Partners Conference. Before taking this role in the company, she managed the Human Resources department for 24 years.
Prior to joining the Crescent team, Ms. Linsley worked in the International Capital Markets Group and High Yield Bond Department of Drexel Burnham Lambert, Inc. Ms. Linsley studied Business Administration at Mesa College in California.
R.P. Channing Rodgers is currently a professor at UCSF with a focus on informatics research and training.
Previously, he was a clinical officer at the FDA in the office of Orphan Product Development, where he leveraged informatics to identify overlooked therapies for rare diseases, created a network-based course for small clinical trials, and reviewed grant and orphan drug applications.
Dr. Rodgers joined the FDA from the NIH, where he had the distinction of being the first physician to actively develop biomedical applications for the Web. At the NIH, he was the founding chair of the National Science Foundation’s Web Consortium, and he co-created the first large catalogued image archive for the Web and devised and directed an Internet-based multimedia course: “The Science of Small Clinical Trials.”
Dr. Rodgers received training at Harvard College and the University of Utah College of Medicine. He received postdoctoral training at the University of London, NCI’s Laboratory of Theoretical Biology, and the International Institute of Cellular and Molecular Pathology (Brussels). He completed training in Clinical Pathology within the Department of Laboratory Medicine in the School of Medicine at the University of California, San Francisco. Dr. Rodgers has published extensively and was formerly the editor-in-chief of the journal Computers in Biology and Medicine.
Dr. Rose is a psychiatrist in private practice in Palo Alto, California. She has over 40 years of experience in treating posttraumatic stress disorder, both acute PTSD and complex PTSD. She has developed and published a model for psychodynamic psychotherapy of PTSD and has published articles and book chapters on these subjects. She has taught extensively for professionals and for the lay public and has consulted to the National Centers for PTSD.
Dr. Rose’s interest in serving on our board stems from both her personal experience of having fibromyalgia and then ME/CFS, and also from having patients in her practice with these illnesses. She is very excited about the pending revolutionary research and about current interventions that have brought her and her patients notable relief.
Dr. Walker is professor of neurology at Emory University and the CEO of Partners for International Health, a non-governmental organization focused on providing advanced medical training to physicians and nurses in underdeveloped countries. The organization is funded by grants from the US Agency for International Development and the Georgia state government.
As director of the internal medicine residency program and director of the junior medicine clerkship and sophomore clinical methods at Emory, Dr. Walker has been deeply involved in medical education, including organizing medical data and evaluating the surgical patient. He has written and edited books that focus on physical diagnosis.
Dr. Walker is particularly interested in applying computer technology to medicine. He was instrumental in establishing a pioneering electronic medical record at Grady Hospital in Atlanta and has been a member, chair, and senior consultant to the Board of Regents of the National Library of Medicine since 1992. From 1997-2008, he served on the White House Regional Fellowship Selection Committee and is currently collaborating with Nobel Prize winner Mohammad Yunus to develop an improved health care system for Bangladesh and other resource-challenged countries.